Sunday, December 22, 2024
- Advertisement -spot_img

TAG

clinical trial data

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

A drug already FDA-approved for people with a rare form of breast cancer has now been shown to improve patients’ long-term survival, new clinical...

Latest news

- Advertisement -spot_img